Sort
50,496 grants matching “lung cancer”
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes
$570,013Mark H Greene · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
$569,922Philip Lazarus · Washington State University · R01 · FY2018 · ES
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$569,902Adam I Marcus · Emory University · P01 · FY2023 · CA
Phenotype Transitions in Small Cell Lung Cancer
$569,839Vito Quaranta · Vanderbilt University · U01 · FY2020 · CA
A new imaging approach to radiotherapy planning for lung cancer
$569,807Rahim R Rizi · University Of Pennsylvania · R01 · FY2020 · CA
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach
$569,753Anna Nolan · New York University School Of Medicine · U01 · FY2022 · OH
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$569,732Suresh S Ramalingam · Emory University · U10 · FY2018 · CA
Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging
$569,699Farhood Farjah · University Of Washington · R01 · FY2024 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$569,682Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$569,651Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2021 · CA
Mechanism of PD1 on cardiac inflammation resolution during heart failure development
$569,625Yingjie Chen · University Of Mississippi Med Ctr · R01 · FY2024 · HL
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments
$569,617Bing-Hua Jiang · Thomas Jefferson University · R01 · FY2020 · CA
Carbon Nanotube X-Ray for in-vivo Cancer and Detection and Treatment
$569,505Otto Z Zhou · Univ Of North Carolina Chapel Hill · U54 · FY2007 · CA
Novel taxane-site tubulin ligands with a dual apoptosis and senescence-inducing mechanism of action
$569,502Hayley M. McDaid · Albert Einstein College Of Medicine · R01 · FY2024 · CA
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2019 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2021 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2023 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2020 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2022 · AI
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing
$569,391Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$569,381Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Comparative functional genomics for lung cancer gene discovery
$569,332Eric Alejandro Sweet-Cordero · Stanford University · R01 · FY2010 · CA
DAP12 and the host response to cryptococcosis
$569,250Lena J Heung · Cedars-Sinai Medical Center · R01 · FY2021 · AI
Deciphering the Role of Mycobiome (Fungus) in Lung Carcinogenesis
$569,229Joyce Huanhuan Chen · University Of Chicago · R37 · FY2025 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,184Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA